BioCentury | Dec 22, 2016
Politics & Policy
Senate price gouging panel doesn’t recommend price controls
...Turing Pharmaceuticals AG (Zug, Switzerland), Retrophin Inc. (NASDAQ:RTRX), Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) and Rodelis Therapeutics...
...burden drug prices are placing on hard-working Americans" (see BioCentury Extra, Dec. 20) . Becky Simon Retrophin Inc. Rodelis Therapeutics Turing...
...burden drug prices are placing on hard-working Americans" (see BioCentury Extra, Dec. 20) . Becky Simon Retrophin Inc. Rodelis Therapeutics Turing...